Deal facts
- Buyer
- Medpal AI plc
- Target
- Universal Pharmacy Ltd
- Deal value
- GBP 45,000
- Announced
- 16 February 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United Kingdom
- Consideration
- cash
Sources
Medpal AI plc has agreed to acquire Universal Pharmacy Ltd in a strategic acquisition valued at £45,000. The transaction was settled entirely in cash and relates to the pharmacy and healthcare services sector. Although the deal was announced on 16 February 2026, the completion date is recorded as 13 February 2026. The target company operates within the United Kingdom, and the buyer is a public limited company focused on artificial intelligence solutions for the industry.
The acquisition represents a significant expansion for the buyer into physical retail healthcare services. Both parties have confirmed that the transaction has been completed as of the stated date. The deal structure involves a straightforward purchase of the target business without any complex earn-out provisions or debt assumptions reported in the available data. The transaction is now final and the target operates as a subsidiary of the acquiring entity.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Medpal AI plc to acquire Universal Pharmacy Ltd
{ "headline": "Completion of Acquisition", "issuer": "Medpal AI PLC (MPAL)", "announcement_date": "2026-02-16T07:00:00", "category_code": "Completion of Acquisition", "body": "Disclaimer* \n\n 16 February 2026 \n\n Medal AI plc \n\n (\"MedPal AI\" or the \"Company\") \n\n Completion of Acquisition of Universal Pharmacy assets and Expansion of Robotic Distribution Facility in Swaffham \n\
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Cronos Group Inc. to acquire CanAdelaar B.V.
Cronos Group Inc. has agreed to acquire CanAdelaar B.V. in a strategic acquisition within the healthcare sector. The Canadian buyer will purchase the Dutch target for a…
- Buyer
- Cronos Group Inc.
- Target
- CanAdelaar B.V.
- Deal value
- EUR 57,500,000
- Deal type
- strategic acquisition
Alaunos Therapeutics, Inc. to acquire Velaris Therapeutics, Inc.
Alaunos Therapeutics, Inc. has agreed to acquire Velaris Therapeutics, Inc. in a strategic acquisition. The transaction was announced on 13 October 2026 and was complete…
- Buyer
- Alaunos Therapeutics, Inc.
- Target
- Velaris Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
STERIS Corporation to acquire Xodus Medical, Inc.
STERIS Corporation has agreed to acquire Xodus Medical, Inc. in a strategic transaction valued at two billion US dollars. The healthcare deal was announced on 11 October…
- Buyer
- STERIS Corporation
- Target
- Xodus Medical, Inc.
- Deal value
- USD 2,100,000,000
- Deal type
- strategic acquisition
Hepion Pharmaceuticals, Inc. to acquire Gravitas Life Sciences, LLC
Hepion Pharmaceuticals, Inc. has agreed to acquire Gravitas Life Sciences, LLC in a strategic acquisition. The transaction, valued at 4.25 million US dollars, was comple…
- Buyer
- Hepion Pharmaceuticals, Inc.
- Target
- Gravitas Life Sciences, LLC
- Deal value
- USD 4,250,000
- Deal type
- strategic acquisition
Buyer history
Medpal AI plc
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
